Sabatino Maione Selected Research

1-aminoindan-1,5-dicarboxylic acid

3/2008

Involvement of subtype 1 metabotropic glutamate receptors in apoptosis and caspase-7 over-expression in spinal cord of neuropathic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sabatino Maione Research Topics

Disease

68	Pain (Aches) 01/2022 - 06/2002
43	Neuralgia (Stump Neuralgia) 01/2022 - 03/2004
39	Hyperalgesia 01/2022 - 05/2004
14	Inflammation (Inflammations) 02/2021 - 06/2010
14	Chronic Pain 01/2021 - 08/2006
8	Cognitive Dysfunction 01/2021 - 04/2009
4	Obesity 10/2021 - 01/2015
4	Brain Concussion (Cerebral Concussion) 01/2020 - 01/2017
3	Mood Disorders (Mood Disorder) 01/2022 - 01/2017
3	Hypersensitivity (Allergy) 10/2021 - 03/2013
3	Peripheral Nervous System Diseases (PNS Diseases) 02/2021 - 01/2009
3	Peripheral Nerve Injuries 01/2021 - 01/2011
2	Body Weight (Weight, Body) 01/2022 - 04/2008
2	Autoimmune Diseases (Autoimmune Disease) 03/2021 - 08/2014
2	Mental Disorders (Mental Disorder) 01/2019 - 01/2016
2	Neuroinflammatory Diseases 01/2018 - 04/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 02/2014
2	Pediatric Obesity 01/2016 - 01/2015
2	Neuroblastoma 01/2016 - 01/2009
2	Asthma (Bronchial Asthma) 01/2015 - 06/2008
2	Osteoporosis 12/2014 - 05/2011
2	Chronic Hepatitis C 02/2014 - 01/2014
2	Liver Diseases (Liver Disease) 02/2014 - 01/2012
2	Autism Spectrum Disorder 07/2012 - 01/2012
2	Contracture 08/2009 - 02/2007
2	Gliosis 03/2008 - 05/2007
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022
1	Hemorrhage 01/2022
1	Weight Gain 01/2022

Drug/Important Bio-Agent (IBA)

18	Formaldehyde (Formol)FDA Link 02/2021 - 06/2002
16	Analgesics (Analgesic Drugs)IBA 01/2022 - 12/2007
16	EndocannabinoidsIBA 10/2021 - 03/2006
15	Glutamic Acid (Glutamate)FDA Link 01/2021 - 03/2004
12	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020 - 09/2008
11	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 08/2006
10	CannabinoidsIBA 12/2019 - 08/2006
10	CarrageenanIBA 09/2019 - 05/2004
8	palmidrolIBA 01/2022 - 01/2011
8	metabotropic glutamate receptor 7IBA 01/2020 - 09/2008
7	metabotropic glutamate receptor 8IBA 01/2020 - 09/2008
6	anandamide (arachidonylethanolamide)IBA 01/2020 - 08/2006
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2019 - 05/2007
6	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 05/2004
6	LigandsIBA 01/2017 - 08/2010
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2021 - 01/2015
4	CytokinesIBA 02/2021 - 08/2006
4	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 07/2007
4	D-Aspartic Acid (D Aspartate)IBA 10/2017 - 01/2015
4	CB2 Cannabinoid ReceptorIBA 01/2016 - 05/2011
4	TRPV1 receptorIBA 01/2016 - 04/2008
4	PlasticsIBA 01/2015 - 04/2009
3	2-pentadecyl-2-oxazolineIBA 01/2022 - 01/2020
3	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 11/2012
3	salicylhydroxamic acid (SHAM)IBA 04/2019 - 10/2015
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018 - 03/2011
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 08/2009
3	arachidonoylserotoninIBA 10/2013 - 12/2007
3	CaspasesIBA 11/2012 - 01/2009
3	Capsaicin (Zostrix)FDA Link 09/2012 - 12/2007
2	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2022 - 01/2021
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 02/2014
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022 - 01/2021
2	OrexinsIBA 10/2021 - 01/2016
2	Monoclonal AntibodiesIBA 10/2021 - 08/2014
2	Vitamin D FDA LinkGeneric 03/2021 - 01/2020
2	Neuroprotective AgentsIBA 03/2021 - 04/2019
2	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 10/2015
2	Opioid Analgesics (Opioids)IBA 01/2021 - 05/2009
2	Metabotropic Glutamate 5 ReceptorIBA 04/2019 - 05/2004
2	CannabidiolIBA 01/2019 - 01/2019
2	5-HT1A Serotonin ReceptorIBA 01/2019 - 10/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 06/2013
2	Pharmaceutical PreparationsIBA 07/2018 - 08/2014
2	EnzymesIBA 01/2018 - 05/2011
2	Peptides (Polypeptides)IBA 01/2018 - 01/2017
2	N,N'-dibenzhydrylethane-1,2-diamine dihydrochlorideIBA 01/2018 - 12/2011
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2017
2	Fluoxetine (Prozac)FDA LinkGeneric 10/2017 - 06/2002
2	Amitriptyline (Elavil)FDA LinkGeneric 10/2017 - 01/2016
2	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2016 - 10/2006
2	Biological ProductsIBA 08/2014 - 01/2007
2	Nerve Growth Factors (Neurotrophins)IBA 02/2014 - 12/2011
2	N-palmitoyl-vanillamideIBA 09/2012 - 04/2011
2	salvinorin AIBA 08/2012 - 09/2011
2	Biomarkers (Surrogate Marker)IBA 07/2012 - 04/2009
2	Mesylates (Mesylate)IBA 03/2012 - 10/2006
2	KaolinIBA 01/2012 - 09/2008
2	cysteinyl-leukotrieneIBA 08/2009 - 02/2007
2	Messenger RNA (mRNA)IBA 01/2009 - 02/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2007 - 08/2006
2	Interleukin-10 (Interleukin 10)IBA 02/2007 - 08/2006
2	N-(4-hydroxyphenyl)arachidonylamide (AM404)IBA 10/2006 - 08/2006
1	2- amino- 4- (3- hydroxy- 5- methylisoxazol- 4- yl)butyric acidIBA 01/2022
1	cinnabarinic acidIBA 01/2022
1	LuteolinIBA 01/2022
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022

Therapy/Procedure

10	Therapeutics 10/2021 - 01/2007
7	Analgesia 01/2022 - 12/2009
3	Ligation 01/2021 - 02/2015
2	Operative Surgical Procedures 01/2018 - 01/2009